A model system for detecting drug impairment of antitumor host defenses.
D000818:Animals; D000937:Antigen-Antibody Reactions; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use; D003561:Cytarabine / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D008466:Mechlorethamine / Q000494:pharmacology / Q000627:therapeutic use; D015122:Mercaptopurine / Q000494:pharmacology / Q000627:therapeutic use; D000432:Methanol / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D009368:Neoplasm Transplantation; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use; D012510:Sarcoma 180 / Q000150:complications / Q000276:immunology* / Q000401:mortality; D013882:Thiosemicarbazones / Q000494:pharmacology / Q000627:therapeutic use; D014184:Transplantation, Homologous; D026681:Vitamin B 6 Deficiency / Q000150:complications
D000970:Antineoplastic Agents; D011725:Pyridines; D013882:Thiosemicarbazones; D003561:Cytarabine; D008466:Mechlorethamine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D000432:Methanol